symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
VIVXF,0.0046,1.206008,1536,567732,0,0.0046-0.1224,-0.0027,Avivagen Inc.,USD,,,,Other OTC,PNK,Drug Manufacturersâ€”Specialty & Generic,https://www.avivagen.com,"Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.",Mr. G. F. Kym Anthony,Healthcare,CA,13,,100 Sussex Drive,Ottawa,ON,K1A 0R6,,0,https://financialmodelingprep.com/image-stock/VIVXF.png,2013-05-02,True,False,False,False,False
